Arxspan Electronic Laboratory Notebook To Help The Broad Institute Manage Discovery Process And Meet Scientific Goals
Arxspan has entered into an agreement with the Broad Institute of MIT and Harvard for use of its ArxLab cloud-based suite of biological and chemical discovery information management tools. The partnership will support the institute’s efforts to electronically manage and share both biological and chemical research information internally and with external collaborators. The ArxLab suite of tools will be used for managing the Institute’s electronic laboratory notebook, compound and assay registration, scientific analysis and search, biological visualization, and inventory management functions.
“We are pleased to be transitioning to the ArxLab software to take advantage of new ELN, compound registration, and inventory management functionalities,” said Andy Phillips, Senior Director of the Center for the Development of Therapeutics and Broad Institute Scholar in Residence. “The ArxLab platform will enable Broad scientists to leverage their data in new ways across a spectrum of research in biology and chemistry. Integration of data is at the heart of what Broad does, and partnering with Arxspan allows us to further increase the velocity of our research.”
The partnership covers use of Arxspan’s ArxLab Notebook, ArxLab Inventory for inventory management, ArxLab Registration for chemical and biological registration, ArxLab Assay for assay data management, ArxLab FT for scientific analysis and search, and ArxDraw for biological visualization. The cloud-based nature of the system allows for secure and efficient sharing of information with external parties.
“The Broad Institute is a leading global biomedical research institute, and we are pleased that they have engaged Arxspan for management and sharing of their chemical and biological research data.” said Peter Rosati, CEO of Arxspan. “We look forward to working together to enable Broad scientists to advance their research programs and share information with the global scientific community.”
About the Broad Institute of MIT and Harvard
The Eli and Edythe L. Broad Institute of MIT and Harvard was launched in 2004 to empower this generation of creative scientists to transform medicine. The Broad Institute seeks to describe all the molecular components of life and their connections; discover the molecular basis of major human diseases; develop effective new approaches to diagnostics and therapeutics; and disseminate discoveries, tools, methods and data openly to the entire scientific community.
Founded by MIT, Harvard and its affiliated hospitals, and the visionary Los Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes faculty, professional staff and students from throughout the MIT and Harvard biomedical research communities and beyond, with collaborations spanning over a hundred private and public institutions in more than 40 countries worldwide. For further information about the Broad Institute, go to broadinstitute.org.